This federal contract award, with ID 36C24225P0619, was issued by the Veterans Health Administration (VHA) under the Department of Veterans Affairs (VA) to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The $13,242.99 firm fixed-price purchase order is for the supply of the medication Jynarque (tolvaptan), which is used to treat autosomal dominant polycystic kidney disease. The contract has an ultimate completion date of May 19, 2025 and was awarded on February 19, 2025. This contract is not set-aside and is open to all qualified vendors. Walgreens Specialty Pharmacy, LLC has been awarded multiple pharmaceutical supply contracts with the VA across various Veterans Integrated Service Networks (VISNs), primarily for specialized medications used to treat rare, chronic, or complex medical conditions.
Generated 2/20/25, 9:26 AM